Announcements Trials
Browse Landscape

Phase

Phase 2 26Phase 3 15Phase NA 8Phase 1 6Phase 1/2 3Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 27Terminated 18Recruiting 13Active not recruiting 8Withdrawn 5Unknown 3Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3

Conditions

Carcinoma, Non-Small-Cell Lung 72Breast Neoplasms 63Neoplasms 59Leukemia, Myeloid, Acute 58Multiple Myeloma 52Colorectal Neoplasms 48Lymphoma 46Stomach Neoplasms 43Recurrence 43Carcinoma, Hepatocellular 43Pancreatic Neoplasms 40Neoplasm Metastasis 39Melanoma 34Prostatic Neoplasms 33Leukemia 30Lymphoma, Non-Hodgkin 27Lymphoma, B-Cell 27Lung Neoplasms 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Glioblastoma 24Ovarian Neoplasms 23Lymphoma, Large B-Cell, Diffuse 21Esophageal Neoplasms 21Carcinoma, Renal Cell 20Myelodysplastic Syndromes 19Leukemia, Lymphocytic, Chronic, B-Cell 19Hematologic Neoplasms 19Colonic Neoplasms 19Head and Neck Neoplasms 18Lymphoma, Mantle-Cell 17

Interventions

Paclitaxel 2Carboplatin 2rucaparib 1etoposide phosphate 1epacadostat 1Topotecan 1Thiotepa 1Peripheral Blood Stem Cell Transplantation 1Filgrastim 1Cyclophosphamide 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Unknown × Fallopian Tube Neoplasms × Clear all
NCT03462212 2021-08-27

MITO25

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 1/2 Unknown
290 enrolled
Gynecologic

Fallopian Tube Neoplasms

NCT02785250 2021-06-18

Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer

ImmunoVaccine Technologies, Inc. (IMV Inc.)

Phase 1/2 Unknown
85 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Neoplasms, Recurrence

NCT00003064 2014-01-06

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer

National Cancer Institute (NCI)

Phase 1/2 Unknown
30 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡